Poxel’s metabolic disorder therapies get orphan drug status in EU

European union flag against parliament in Brussels


The European Commission (EC) granted orphan drug designation to Poxel’s (OTC:PXXLF) PXL770 and PXL065 to treat adrenoleukodystrophy (ALD).

ALD is a type of hereditary condition which damages the membrane (myelin sheath) that insulates nerve cells in the brain. The disorder is the

Source link

5 Trading strategies to make money

Looking to boost your trading profits?

Get you copy of our FREE Ebook Now !!!